No photo of Jan Wysocki

View Scopus Profile

Jan Wysocki

  • 1494 Citations
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Training Experience

2010Postdoctoral Fellowship, Northwestern University Feinberg School of Medicine

Education/Academic qualification

PhD, University of Rostock

… → 1995

MD, University of Rostock

… → 1994

Fingerprint Dive into the research topics where Jan Wysocki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Urinary Renin Angiotensin System in Diabetes

Batlle, D., Molitch, M. E., Rademaker, A. W. & Wysocki, J.

National Institute of Diabetes, Digestive and Kidney Diseases

6/15/15 → 4/30/20

Project: Research project

    • ACE2 as Therapeutic Target for Kidney Disease in Diabetic Mice

    Batlle, D. & Wysocki, J.

    JDRF International

    12/1/07 → 6/30/11

    Project: Research project

    Research Output

    Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent

    Serfozo, P., Wysocki, J., Gulua, G., Schulze, A., Ye, M., Liu, P., Jin, J., Bader, M., Myöhänen, T., García-Horsman, J. A. & Batlle, D., Jan 1 2020, In : Hypertension (Dallas, Tex. : 1979). 75, 1, p. 173-182 10 p.

    Research output: Contribution to journal › Article

    • 11 Scopus citations

    An update on ACE2 amplification and its therapeutic potential

    Marquez, A., Wysocki, J., Pandit, J. & Batlle, D., 2020, (Accepted/In press) In : Acta Physiologica.

    Research output: Contribution to journal › Review article

    Open Access

    • Soluble angiotensin-converting enzyme 2: A potential approach for coronavirus infection therapy?

    Batlle, D., Wysocki, J. & Satchell, K., Mar 1 2020, In : Clinical science. 134, 5, p. 543-545 3 p.

    Research output: Contribution to journal › Article

    Open Access
    • 40 Scopus citations

    Novel variants of angiotensin converting enzyme-2 of shorter molecular size to target the kidney renin angiotensin system

    Wysocki, J., Schulze, A. & Batlle, D., Dec 2019, In : Biomolecules. 9, 12, 886.

    Research output: Contribution to journal › Article

    Open Access
    • 6 Scopus citations

    Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus

    For the Diabetes Control, Complications Trial (DCCT)/Epidemiology of Diabetes Interventions, Complications (EDIC) Study, Oct 1 2019, In : Physiological reports. 7, 19, e14242.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations